|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Á¦ ¸ñ |
MrhikDSjLjMbz |
|
ÀÌ ¸§ |
Lifestile |
³¯ Â¥ |
2018/06/28 |
Á¶ ȸ |
1 |
|
I'm a partner in duratia tablets Under the terms of the deal, Ablynx will receive an upfront payment of $175 million and may receive additional payments of up to $665 million, depending on the success of its product ALX-0061, which is currently in mid-stage clinical trials.
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|